Health Trials

About this trial

This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.

Eligibility criteria

Qualifiers

existing indication for radiation therapy

minimum age 18 years, no upper age limit

capacity for consent

Informed consent

Disqualifiers

contraindication for MRI (claustrophobia, metallic implants not applicable for MRI

pregnancy

Trial design

Treatments tested in this trial

  • Radiotherapy on the MR-Linac
  • Imaging on the MR Linac

Treatment groups

472 Participants
are divided into 9 treatment groups

9

Treatment groups

See each treatment group below.

Locations

1
University Hospital Tübingen, Department of Radiation Oncology72076, TübingenBaden-Wurttemberg, Germany

Sponsors and collaborators

University Hospital Tuebingen

Lead sponsor

Source ClinicalTrials.gov